title: Implementing the findings of the TICOPA trial in clinical practice: challenges in implementation and how information technology can bridge the gap.
abstract: As in rheumatoid arthritis, treating to target in psoriatic arthritis (PsA) has been shown to improve outcomes over standard therapy. As a result of this, the European League Against Rheumatism (EULAR) updated recommendations for the management of PsA now recommend a treat-to-target approach for all patients with PsA. However, translating the results of this research remains challenging in clinical practice. Prolonged consultation time associated with implementing this into practice can be minimised using a simple to calculate but inclusive target for treatment and assessing this within information technology (IT) systems. IT systems can combine physician and patient-reported outcomes, use algorithms to calculate any target and even be used to suggest follow up times based on previous data. Utilising these tools can help to make optimal treatment of arthritis feasible in routine clinical practice.
authors.affiliation: Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; and Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. l.c.coates@leeds.ac.uk.
authors.forename: Laura C
authors.initials: LC
authors.lastname: Coates
mesh_terms: D000465:Algorithms; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003661:Decision Support Techniques; D019317:Evidence-Based Medicine; D006801:Humans; D008490:Medical Informatics; D010347:Patient Care Planning; D011237:Predictive Value of Tests; D012219:Rheumatology / Q000379:methods*; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents